Search Results - "Senoo, Tomonori"

Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice by Toyoda, Hidenori, Leong, Jennifer, Landis, Charles, Atsukawa, Masanori, Watanabe, Tsunamasa, Huang, Daniel Q., Liu, Joanne, Quek, Sabrina Xin Zi, Ishikawa, Toru, Arai, Taeang, Yokohama, Keisuke, Chuma, Makoto, Takaguchi, Koichi, Uojima, Haruki, Senoo, Tomonori, Dang, Hansen, Maeda, Mayumi, Hoang, Joseph, Le, Richard H., Yasuda, Satoshi, Thin, Khin N., Tran, Sally, Chien, Nicholas, Henry, Linda, Asai, Akira, Fukunishi, Shinya, Cheung, Ramsey, Lim, Seng Gee, Trinh, Huy N., Nguyen, Mindie H.

“…Background and Aims Real‐world data for treatment effectiveness and renal outcomes in chronic hepatitis B (CHB) patients who were switched to the new and safer…”
Get full text

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study by Morishita, Asahiro, Oura, Kyoko, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Shi, Tingting, Himoto, Takashi, Tatsuta, Miwa, Moriya, Akio, Senoo, Tomonori, Tsutsui, Akemi, Nagano, Takuya, Takaguchi, Koichi, Ono, Masafumi, Masaki, Tsutomu

“…Background This retrospective, multicenter study evaluated the effect of pemafibrate treatment on liver function and fibrosis by liver function tests (LFTs)…”
Get full text

Clinical outcomes of hepatitis C virus elimination using glecaprevir and pibrentasvir in hemodialysis patients: A multicenter study by Morishita, Asahiro, Ogawa, Chikara, Moriya, Akio, Tani, Joji, Yoneyama, Hirohito, Fujita, Koji, Oryu, Makoto, Senoo, Tomonori, Takaguchi, Koichi, Masaki, Tsutomu

“…Aim The incidence of hepatitis C virus (HCV) infection is much higher in hemodialysis patients than that in healthy individuals. The prognosis of hemodialysis…”
Get full text

Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy by Oura, Kyoko, Morishita, Asahiro, Manabe, Takushi, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Fujita, Koji, Mimura, Shima, Tani, Joji, Ono, Masafumi, Ogawa, Chikara, Moriya, Akio, Senoo, Tomonori, Tsutsui, Akemi, Nagano, Takuya, Takaguchi, Koichi, Himoto, Takashi, Masaki, Tsutomu

“…Although there have been advances in the prevention and diagnosis of hepatocellular carcinoma (HCC) in recent years, many HCC patients are still diagnosed with…”
Get full text

328: REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VS NON-PI DIRECT ACTING ANTIVIRALS (DAAS) IN DECOMPENSATED HCV CIRRHOSIS: A REAL-C STUDY by Wong, Yu Jun, Tran, Sally, Huang, Chung-Feng, Hsu, Yao-Chun, Preda, Carmen M., Toyoda, Hidenori, Liu, Joanne, Jun, Dae Won, Landis, Charles, Huang, Daniel, Gila, Andrei B., Negoita, Livia, Yasuda, Satoshi, Tseng, Cheng-Hao, Tsai, Pei-Chien, Uojima, Haruki, Nozaki, Akito, Chuma, Makoto, Atsukawa, Masanori, itokawa, norio, Iio, Etsuko, Lam, Carla, Watanabe, Tsunemasa, Keisuke, Yokohama, Abe, Hiroshi, Enomoto, Masaru, Tamori, Akihiro, Lee, Dong-Hyun, Jun, Mijung, Maeda, Mayumi, Nakanishi, Akiko, Yeh, Ming-Lun, Chuang, Wan-Long, Huang, Jee-Fu, Dai, Chia-Yen, Ishikawa, Toru, Takaguchi, Koichi, Senoo, Tomonori, Trinh, Huy N., Takahashi, Hirokazu, Eguchi, Yuichiro, Quek, Sabrina X., Haga, Hiroaki, Ogawa, Eiichi, Wong, Grace L., Buti, Maria, Fukunishi, Shinya, Ueno, Yoshiyuki, Yuen, Man-Fung, Tanaka, Yasuhito, Lim, Seng Gee, Cheung, Ramsey, Yu, Ming-Lung, Nguyen, Mindie H.

Get full text

Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study by Morishita, Asahiro, Tani, Joji, Nomura, Takako, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Shi, Tingting, Yamana, Hiroki, Matsui, Takanori, Takata, Tadayuki, Sanomura, Takayuki, Nishiyama, Yoshihiro, Himoto, Takashi, Tomonari, Tetsu, Moriya, Akio, Senoo, Tomonori, Takaguchi, Koichi, Masaki, Tsutomu

“…EB-TACE has recently been performed because of its lower hepatotoxicity compared to cTACE in less advanced HCC. However, local recurrence at the tumor margins…”
Get full text